.
Few studies in the severely obese correlating clinical and biochemical data with morphology of the liver are available. The early reports of Zelman (1952) and Westwater and Fainer (1958) were based on small series with limited laboratory data and all but one of the patients were males. The introduction of small bowel bypass to achieve weight reduction stimulated considerable controversy about the effects of these surgical procedures on the liver (Payne and DeWind, 1969; Drenick, Simmons, and Murphy, 1970; Juhl, Christoffersen, Baden, and Quaade, 1971;  Salmon, 1971; Shibita, Mackenzie, and Huang, 1971; Meyerowitz, 1972) .
However, the influence of diverse factors (age, sex, corpulence, metabolic alterations) on hepatic morphology is not well known. In this paper, we study the interrelations among several biochemical parameters, and we seek possible links between biochemical and clinical information with hepatic morphology.
Materials and Methods
The subjects studied were hyperphagic individuals undergoing jejunoileal bypass. The criteria for selection included obesity mainly due to hyperphagia, a minimum of 50 kg overweight, and a Received for publication 19 July 1973. 7', good surgical risk. Clinical data were obtained through questioning by one of the authors in more than half of the patients and from medical records or mailed questionnaires in the remainder. Except for diabetes and obesity, no patient had conditions known to alter hepatic histology (active gastrointestinal disease, anaemia, history of alcoholism, hepatitis, or drug addiction). Few patients were taking medicines. Seventeen women taking oral contraceptives were included because after analysis of the data their inclusion did not significantly affect the results.
The corpulence was expressed as percentage obesity which was calculated by dividing patient's weight by medium frame ideal weight of the Metropolitan Life Insurance Company as given by Geigy (1962) ; 0 represents the ideal and 100 is double the desired weight.
Fasting serum calcium, phosphorus, cholesterol, uric acid, blood urea nitrogen, total protein, total bilirubin, alkaline phosphatase, lactic acid dehydrogenase, and glutamic oxalacetic transaminase (GOT) were done in all patients on the Technicon SMA 12/601. The three-hour glucose tolerance test (OGTT) was carried out following the recommendations of the University Diabetes Program and the American Diabetes Association Committee on Relationship between hepatic morphology and clinical and biochemical findings Statistics (1969) . The plasma glucose was determined by the alkaline ferricyanide method in the AutoAnalyzer. In the bromsulphalein (BSP) retention test, 5 mg of dye per kg of body weight was injected in patients weighing 100 kg or less. Heavier subjects received 500 mg. Retention of the dye was measured by spectrophotometry. Fasting triglycerides (Tg) were determined enzymatically using a commercially available kit2. The method of Noble (1969) was used for the electrophoretic separation of plasma lipoproteins in agarose gel. The prothrombin time (PT) was estimated by the method of Biggs and Macfarlane as modified by Gaston, Brooks, Blumenthal, and Miller (1971) . Serum folates were assayed by a microbiological technique employing Lactobacillh,s casei.
The upper limits of normal in this laboratory, established from healthy blood donors, are: cholesterol, 260 mg/100 ml; uric acid, 8-3 mg/100 ml in men and 7-7 mg/100 ml for females; GOT, 50m U/ ml. The lower limits of normal for serum folates is 6 ng/ml. We consider an OGTT result 'normal' when plasma glucose at one hour is less than 175 mg/100 ml and at two hours less than 130 mg/100 ml; 'diabetic' if the sum of the fasting, one-, two-, and three-hour values (in mg/100 ml) is (Stokes and Wynn, 1971 ), but numbers were too small and scattered in subgroups to draw conclusions or to affect the overall results.
In 21 patients (9 6 %) the serum cholesterol was between 261 and 300 mg/100 ml and in 11 patients (5%) it was over 300 mg/100 ml. No relationship was evident between hypercholesterolaemia and other factors, except possibly age.
Lipoprotein electrophoresis usually revealed normal or type IV patterns (of Fredrickson, Levy, and Lees, 1967) . As expected, the type IV patterns occurred in subjects with highest Tg levels.
A single determination revealed hyperuricaemia in 20 (38-4 %) men and in 35 (20.7 %) women, which is a significant sex difference (p < 0-025). After taking into account the abnormalities of carbohydrate metabolism, no association was found between uricaemia and corpulence, age, or Tg (or among the last three parameters).
The BSP retention test was done on I I I occasions; 50 patients retained between 7 and 20% of the dye at 45 minutes, 10 subjects had over 20% retention, and in 51 patients the results were normal.
Serum folates between 2 and 5 9 ng/ml occurred in 40 (29-8%) of 134 patients who were not anaemic. No other abnormalities (clinical, metabolic, or histology of the liver) could be associated with low folates.
Protein electrophoresis, as well as tests to evaluate endocrine (thyroid, adrenals) and haematological status, consistently gave normal results. The alkaline phosphatase, PT, albumin, and total bilirubin were abnormal in less than 5% of the patients, therefore, they were not compared with other functions. Thirty-seven patients had slightly elevated GOT, and of these, eight had no or mild pathological findings in the liver, 15 showed some hepatic fibrosis, 22 had marked fatty change, and 16 parenchymal or portal inflammation. Conversely, 15 out of 24 subjects with hepatic fibrosis and 22 of 40 with marked hepatic steatosis had elevations of the GOT. Mild or moderate hepatic steatosis was not associated with GOT elevations. Bromsulphalein was not reliable in predicting hepatic alterations in this study.
Discussion
The results of this study underscore the importance of carbohydrate metabolism in exogenous obesity. The majority of the patients had either an 'abnormal' or a 'diabetic' OGTT. Moreover, diabetes, when present, was mild in most patients. These facts are interpreted as evidence of the obesity-associated character of the carbohydrate disturbance. A key mediator, extensively studied in recent years, is insulin. Hyperinsulinism has been linked to corpulence, hyperglycaemia, and hypetriglyceridaemia (Rosselin, Claude, Eschwege, Patois, Warnet, and Richard, 1971) . The relationship between insulin and adipose tissue has beenextensivelystudied(Bj6rntorp, Berchtold, Holm, and Larsson, 1971) , and the hyperinsulinism of obesity has been thought as mainly due to the 'resistance' of the adipocyte to the action of insulin. Surprisingly little is known about the role that the liver may play in this hyperinsulinism. Abnormal glucose tolerance and high insulin levels also occur in cirrhosis, but it has been suggested that these are caused by shunting of insulin-containing portal blood (Conn, Schreiber, and Elkington, 1971; McCullough, Tzargoumis, Greenberger, and Linscheer, 1971) .
The other two frequently elevated values in this study were the Tg and uric acid. To interpret Tg levels, the influence of age (Schaefer, 1964) and probably sex should be taken into account; age-adjusted criteria are used to determine the upper limits of 'normal' (Fredrickson et al; 1967) . However, there is little information on the possible influence of sex on Tg values. In our material, hypertriglyceridaemia was more closely associated with sex and age variation than with corpulence, abnormal carbohydrate metabolism, or hyperuricaemia. These findings tend to parallel those of other studies in normal, mildly obese and diabetic individuals (Allard and Goulet, 1968; Plauchu, Pousset, Montgolfier, Guibert, and Kressmann, 1971) .
Inasmuch as the method used by us is not very specific for uric acid, and furthermore, serum urate levels fluctuate fairly widely even in the same subject (Goldstein, Becker, and Moore, 1972) , the uric acid values should be interpreted with caution. Even recognizing such limitations, our data show higher uric acid levels in men than in women.
The coexistence of high Fg, hyperglycaemia, and obesity is well known (Emmerson and Knowles, 1971; Mertz, 1972) , although a precise link among these factors is difficult to establish. Except between uricaemia and hyperglycaemia (and only in females), we were unable to find a statistically significant association among these parameters.
Elevations of GOT, even slight, correlated well with hepatic fibrosis and inflammation, and to a lesser extent with hepatic steatosis. Determinations of GOT have more practical value when there are no other conditions known to affect the GOT, as in our patients. In contrast to GOT, BSP was a poor test in predicting the severity of hepatic alterations. This may be explained by the difficulty in calculating an adequate dose and by the irregular distribution of the dye in the obese.
Hepatic steatosis in obesity has long been recognized. In the first studies, carried out in males, no relationship could be established between hepatic pathology and any biochemical data. We report here similar findings in men. However, it should be pointed out that the number of males in the present and in previous studies is relatively small. To our knowledge, no comparison of biochemical and clinical information with histology of the liver has been previously attempted in markedly obese females. In investigations on diabetic patients, mostly mildy obese females, the degree of hepatic fatty metamorphosis depended on the degree of overweight not on the severity of diabetes (Beringer and Thaler, 1970; Wasastjerna, Reissell, Karjalainen, and Ekelund, 1972) . In our material impairment of carbohydratemetabolism seems more important than corpulence in producing hepatic changes. Perhaps it might be concluded that, at least in females, the coexistence of both obesity and 'diabetic' alteration is much more likely to cause fatty liver than if only one factor is present.
Gout has been implicated as a cause of fatty liver (Hennecke and Sudhoff, 1970) , but it remains unclear whether the uric acid alteration or the frequently coexisting obesity and 'diabetes' are responsible for the hepatic steatosis. Our data are inconclusive in this respect, but carbohydrate alterations seem to play a more important role than gout. Hypercholesterolaemia (Leevy, 1962) , hypertriglyceridaemia, or high fatty acids, per se, are not known to be associated with liver damage. This is also evident in the present work.
We report here a close association between menstrual disturbances and hepatic abnormalities in young obese females. This, to our knowledge, has not been previously described, and further studies are needed.
Our data suggest both unpredictable and more severe liver involvement in obese menthanin women. Review of other reports (Zelman, 1953; Westwater and Fainer, 1958; Meyerowitz, 1972) appears to support this view. The reason for this sex difference is not clear. Seemingly, the alterations which should coexist with obesity to cause hepatic abnormalities are less common or less severe in females.
Histologically, although fatty change in the liver was common, significant fibrosis was infrequent, and when the latter occurred, necrosis and inflammation often coexisted. Thus, the last two factors, rather than steatosis, are the important fibrogenetic stimuli in the liver. This concept is held by most investigators (Schaffner and Popper, 1970; Smetana, 1972) studying fatty livers of diverse aetiology. The role of lipogranulomas (Christoffersen, Braendstrup, Juhl, and Poulsen, 1971) , if any, awaits further investigation (in our material it did not seem to be prominent). The pathway leading to cirrhosis in the obese-a relatively uncommon event-is probably similar to the one operating in other micronodular cirrhosis.
